Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule 377193004
SNOMED CT code
SNOMED code | 377193004 |
---|---|
name | Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule |
status | active |
date introduced | 2002-07-31 |
fully specified name(s) | Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
synonyms | Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule |
attributes - group0 | |
Has manufactured dose form | Oral capsule 420692007 |
Has unit of presentation | Capsule 732937005 |
attributes - group1 | |
Has BoSS | Caffeine 255641001 |
Has presentation strength numerator unit | mg 258684004 |
Has presentation strength denominator unit | Capsule 732937005 |
Has precise active ingredient | Caffeine 255641001 |
attributes - group2 | |
Has BoSS | Aspirin 387458008 |
Has presentation strength numerator unit | mg 258684004 |
Has presentation strength denominator unit | Capsule 732937005 |
Has precise active ingredient | Aspirin 387458008 |
attributes - group3 | |
Has BoSS | Butalbital 387563005 |
Has presentation strength numerator unit | mg 258684004 |
Has presentation strength denominator unit | Capsule 732937005 |
Has precise active ingredient | Butalbital 387563005 |
parents | Aspirin and butalbital and caffeine only product in oral dose form 778361007 |
hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as oral dose form 440131009 Aspirin-containing product in oral dose form 358427004 Aspirin- and butalbital- and caffeine-containing product in oral dose form 767919008 Aspirin and butalbital and caffeine only product in oral dose form 778361007 Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral capsule 377193004 |
ancestors | sorted most to least specific
|
cpt crosswalks |
Thank you for choosing Find-A-Code, please Sign In to remove ads.